Stanford Training Program in Lung Biology
斯坦福大学肺生物学培训计划
基本信息
- 批准号:10379231
- 负责人:
- 金额:$ 38.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
This competitive renewal Stanford T32 Training Grant Proposal combines pediatric and adult pulmonary
programs in order to select the most promising Trainees and provide an optimally diverse interdisciplinary
training experience centered on pulmonary biology. Dr. David Cornfield, the pediatric chief, Dr. Mark Nicolls,
the adult chief share Program Director responsibilities; each bringing unique and complementary skills to the
leadership position. In the first few years of this new T32 funded in 2016, we have accomplished our goal of
creating a more integrated and cohesive academic culture. We describe the excellent progress of our first nine
trainees. We have developed 38 Mentors from the Stanford biomedical community with a strong track record of
training and academic productivity and 2 Junior Mentors. Based on the expertise of our Mentors, we have
identified nine domains of excellence from which trainees can choose a primary focus for an individualized
development plan. These research areas include: 1) Vascular Disease, 2) Stem Cells & Lung Development, 3)
Genetics & Genomics, 4) Lung Injury & Repair, 5) Lung Immunology, 6) Lung Microbiome, 7) Lung Cancer and
8) Outcomes Research, and 9) Imaging.
The grant proposal describes a process by which fellows are recruited to Stanford, exposed to research areas,
introduced to Mentors, and move through a selective process designed to identify Trainees with the best
chance of success in academic medicine for T32 support. We describe a well-supported and carefully
constructed system of oversight to promote recruitment of underrepresented minorities. All T32 trainees will
have an individualized development plan that includes a core curriculum and electives appropriate to their
research domain. Through a longitudinal monthly T32 meeting lead by the PDs and quarterly informal
meetings with T32 trainees, Mentors and PDs, Trainees will be immersed in a microculture of academic
pulmonary medicine. A Scientific Oversight Committee identifies appropriate coursework and ensures ongoing
and timely Trainee progress. We have assembled an experienced Internal Advisory Committee at Stanford and
an acclaimed group of national leaders in pulmonary medicine for the External Advisory Committee. We will
utilize regular feedback from these groups, the Mentors and Trainees to identify programmatic strengths and
weaknesses and reassess our processes to adjust, adapt and improve the T32 fellowship. As a world
university embedded in a vibrant local economy, Stanford is particularly well situated to develop and inspire the
next generation of physician-scientists and clinical researchers.
项目摘要
这项竞争性更新斯坦福大学T32培训补助金提案将儿科和成人肺
计划,以选择最有前途的学员并提供最佳多元化的跨学科
以肺生物学为中心的培训经验。大卫康菲尔德医生儿科主任马克尼科尔斯医生
成人酋长分享项目总监的职责;每个人都为项目带来独特和互补的技能。
领导地位。在2016年资助的新型T32的最初几年里,我们已经实现了我们的目标
创造一个更加融合和凝聚力的学术文化。我们描述了我们的前九个出色的进展
实习生我们已经从斯坦福大学生物医学界培养了38名导师,
培训和学术生产力和2名初级导师。基于导师的专业知识,我们
确定了九个卓越领域,学员可以从中选择一个主要重点,
发展规划这些研究领域包括:1)血管疾病,2)干细胞和肺发育,3)
遗传学和基因组学,4)肺损伤和修复,5)肺免疫学,6)肺微生物组,7)肺癌和
8)结果研究和9)成像。
拨款申请描述了一个过程,通过这个过程,研究员被招募到斯坦福大学,接触研究领域,
介绍给导师,并通过一个选择性的过程,旨在确定最好的学员
在学术医学上获得T32支持的成功机会。我们描述了一个得到充分支持和仔细
建立监督制度,促进征聘代表性不足的少数群体。所有T32学员将
有一个个性化的发展计划,包括核心课程和选修课适合他们的
研究领域。通过由项目主任牵头的每月T32纵向会议和每季度非正式会议
与T32学员,导师和PD会面,学员将沉浸在学术的微观文化中,
肺内科科学监督委员会确定适当的课程作业并确保持续进行
及时培训学员。我们在斯坦福大学组建了一个经验丰富的内部咨询委员会,
一个著名的小组的国家领导人在肺部医学的外部咨询委员会。我们将
利用这些团体、导师和学员的定期反馈,确定方案的优势,
我们的团队将重新评估我们的流程,以调整,适应和改进T32奖学金。作为世界
作为一所植根于充满活力的地方经济的大学,斯坦福大学特别适合发展和激励
下一代的医生科学家和临床研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID N. CORNFIELD其他文献
DAVID N. CORNFIELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID N. CORNFIELD', 18)}}的其他基金
Postnatal Lung Development: Mechanisms of Molecular and Vascular Development
产后肺发育:分子和血管发育机制
- 批准号:
7936134 - 财政年份:2009
- 资助金额:
$ 38.24万 - 项目类别:
Postnatal Lung Development: Mechanisms of Molecular and Vascular Development
产后肺发育:分子和血管发育机制
- 批准号:
7861290 - 财政年份:2009
- 资助金额:
$ 38.24万 - 项目类别:
Molecular regulation of pulmonary vascular KCa Channels
肺血管 KCa 通道的分子调控
- 批准号:
6940632 - 财政年份:2003
- 资助金额:
$ 38.24万 - 项目类别:
Molecular Regulation of Pulmonary Vascular KCa Channel
肺血管 KCa 通道的分子调控
- 批准号:
8656382 - 财政年份:2003
- 资助金额:
$ 38.24万 - 项目类别:
Molecular regulation of pulmonary vascular KCa Channels
肺血管 KCa 通道的分子调控
- 批准号:
6773818 - 财政年份:2003
- 资助金额:
$ 38.24万 - 项目类别:
Molecular Regulation of Pulmonary Vascular KCa Channel
肺血管 KCa 通道的分子调控
- 批准号:
8490606 - 财政年份:2003
- 资助金额:
$ 38.24万 - 项目类别:
Molecular Regulation of Pulmonary Vascular KCa Channel
肺血管 KCa 通道的分子调控
- 批准号:
8288668 - 财政年份:2003
- 资助金额:
$ 38.24万 - 项目类别:
相似国自然基金
胚胎脑发育的分子机理:lgl2(late gestation lung 2)蛋白质的生物学功能的研究
- 批准号:30470854
- 批准年份:2004
- 资助金额:18.0 万元
- 项目类别:面上项目
相似海外基金
Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
- 批准号:
MR/Y003683/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Research Grant
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Uncovering the epigenetic face of lung fibrosis for discovery of novel biomarkers and treatments.
揭示肺纤维化的表观遗传面,以发现新的生物标志物和治疗方法。
- 批准号:
MR/X032914/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Fellowship
Persistent micro- and nanoplastics as triggers for interstitial lung disease
持久性微塑料和纳米塑料是间质性肺病的诱因
- 批准号:
MR/Y012682/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Research Grant
気道上皮バリアに着目した肺NTM症Lung-on-a-chipモデルの構築と応用
关注气道上皮屏障的肺NTM疾病芯片肺模型的构建与应用
- 批准号:
24K19096 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Bioactive fragments of the extracellular matrix orchestrate lung epithelial cell repair.
细胞外基质的生物活性片段协调肺上皮细胞修复。
- 批准号:
BB/Y004183/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Research Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
- 批准号:
MR/X03383X/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Fellowship
A Cyber-Physical System for Unified Diagnosis and Treatment of Lung Disease
肺部疾病统一诊疗的网络物理系统
- 批准号:
MR/Y011694/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Fellowship
Tractable human distal lung organoid model as a new efficient tool to study mesenchymal-epithelial interactions in COPD
易处理的人远端肺类器官模型作为研究慢性阻塞性肺病间充质-上皮相互作用的新有效工具
- 批准号:
NC/Y500641/1 - 财政年份:2024
- 资助金额:
$ 38.24万 - 项目类别:
Training Grant